Umbilical cord stem cell therapy for recent stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a single infusion of cells from umbilical cord blood (stem cells) can help people recover from a recent moderate-to-severe stroke. It aims to see if this treatment is safe and could improve recovery when given within the first two days after a stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years of age or older (any gender)
- Has had a stroke affecting the front part of the brain, and can start treatment within 48 hours of symptom onset
- Moderate stroke severity (score of 6–20 on the standard stroke scale)
- Was able to do everyday activities without help before the stroke (score of 0–1 on the modified Rankin Scale)
- Generally healthy other than the stroke — no severe heart, lung, kidney, liver, blood, or autoimmune diseases, and no serious psychiatric or neurological conditions
- No plans for or prior clot-removal procedure for this stroke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether special cells from human placenta can help your brain recover after a recent stroke. The treatment is given as an injection and aims to reduce long-term disability.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This study tests whether an infusion of stem cells from umbilical cord blood can help people recover from a recent ischemic stroke (a stroke caused by a blocked blood vessel) who have paralysis on one side of their body. The treatment aims to improve recovery and reduce disability.
This study tests a new treatment using exosomes (tiny particles from stem cells) given through a vein to people who recently had an ischemic stroke. It aims to see if this treatment is safe and helps improve recovery.
This trial tests a safe, non-invasive brain stimulation technique called tDCS to help people recover from a recent stroke. It's for people who cannot have the standard clot-removal procedure and who can start treatment within 24 hours of their stroke.
This trial tests whether a single infusion of umbilical cord stem cells can help people recover from a recent ischemic stroke (stroke caused by a clot). It is for patients who have had their stroke within the last 72 hours and have moderate to severe symptoms.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.